CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- 4 Open-market sale 10% owner sold 1,050,000 shares at $18.00 ($18,900,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 13,516 shares (option exercise)
- 4 Planned sale Chief Medical Officer sold 1,490 shares at $16.65 ($24,816)
- 4 Planned sale Chief Development Officer sold 1,490 shares at $16.66 ($24,817)
- 4 Planned sale President and CEO sold 5,210 shares at $16.66 ($86,779)
- 4 Exercise or conversion SVP, Finance, Chief Acct Offcr acquired 10,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $16.60 ($83,000)
- 4 Open-market buy 10% owner bought 448,217 shares at $15.17 ($6,799,004)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 12 · 230 filings